Results 21 to 30 of about 74,756 (267)

The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy

open access: yesInternational Journal of Endocrinology, 2018
Polycystic ovary syndrome is a highly frequent reproductive-endocrine disorder affecting up to 8–10% of women worldwide at reproductive age. Although its etiology is not fully understood, evidence suggests that insulin resistance, with or without ...
Eduardo Spinedi, Daniel P. Cardinali
doaj   +1 more source

Characteristics of polycystic ovary syndrome throughout life

open access: yesTherapeutic Advances in Reproductive Health, 2020
Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age. It is a complex disease in which genetic, endocrine, environmental, and behavioral factors are intertwined, giving rise to a heterogeneous phenotype with ...
Yvonne V. Louwers, Joop S.E. Laven
doaj   +1 more source

Polycystic ovary syndrome [PDF]

open access: yesBMJ, 2011
Independently increases the risk of adverse pregnancy and birth outcomes Polycystic ovary syndrome is a common condition. The reported incidence varies between 3% and 15% of women of reproductive age, depending on the population studied and the diagnostic criteria applied,1 which include hyperandrogenism, anovulation, and polycystic ovaries.
openaire   +3 more sources

A new model for predicting the occurrence of polycystic ovary syndrome: Based on data of tongue and pulse

open access: yesDigital Health, 2023
Background and objective Polycystic ovary syndrome is one of the most common types of endocrine and metabolic diseases in women of reproductive age that needs to be screened early and assessed non-invasively.
Weiying Wang   +8 more
doaj   +1 more source

Polycystic ovaries and polycystic ovary syndrome

open access: yesGynecological Endocrinology, 1987
In the 50 years or so since the description by Irving F. Stein and Michael L. Leventhal of their finding of unexpectedly enlarged ovaries in a group of women with amenorrhea1, the syndrome we associate with their names has become widely recognized, variously interpreted and a subject of continual fascination for scores of reproductive scientists and ...
openaire   +2 more sources

Leptin, polycystic ovaries and polycystic ovary syndrome [PDF]

open access: yesHuman Reproduction Update, 1999
As soon as leptin was discovered four years ago, its potential as a player in the polycystic ovary syndrome (PCOS) was explored in a primitive way, though little light was shed on the enigma that is PCOS. As a second wave of leptin research is now available, we review how the expanded role of the cytokine in reproduction might yet impact upon our ...
H S, Jacobs, G S, Conway
openaire   +2 more sources

Effect Differences of Omega‐3 Fatty Acids From Plant Oil and Fish Oil on Human Health

open access: yesAgriFood: Journal of Agricultural Products for Food, EarlyView.
Omega‐3 fatty acids in plant oil is no less than fish oil on human health. ALA in plant oil takes directly healthy effects without conversion to DHA and EPA. Plant oil can be substitutes for fish oil to support partial ω‐3 fatty acids. For people who cannot afford fish oil, plant oil is also good for public health.
Mengxue Fang   +3 more
wiley   +1 more source

Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?

open access: yesArchives of Endocrinology and Metabolism, 2019
Objective: Nonalcoholic fatty liver disease is the commonest diffuse liver disease, of which women with polycystic ovary syndrome are at an increased risk.
Na Di   +8 more
doaj   +1 more source

Identification of Compound Heterozygous CYP11A1 Variants via Reanalysis of Clinical Sequencing Data

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT A molecular diagnosis is currently achievable in approximately 50% of patients assessed by clinical geneticists at tertiary care centres. Next‐Generation Sequencing Panels contain a defined group of genes associated with a clinically defined set of phenotypes.
Ana Acosta Bedón   +10 more
wiley   +1 more source

‘Everything’s from the inside out with PCOS’: Exploring women’s experiences of living with polycystic ovary syndrome and co-morbidities through Skype™ interviews

open access: yesHealth Psychology Open, 2015
Polycystic ovary syndrome is an endocrine disorder affecting 1 in 10 women. Women with polycystic ovary syndrome can experience co-morbidities, including depressive symptoms.
Sophie Williams   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy